Dihydroartemisinin attenuates acetic acid-induced ulcerative colitis in rats: Suppression of inflammation and modulation of NFκβ/TNF-α/RIPK1-mediated necroptosis and apoptosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Dihydroartemisinin (DHA) effectively treats ulcerative colitis (UC) in rats by reducing oxidative stress and inflammation. DHA also modulates key proteins in cell death pathways, offering a potential new therapy for UC.
Area Of Science
- Gastroenterology
- Pharmacology
- Cell Biology
Background
- Ulcerative colitis (UC) involves oxidative stress and inflammation.
- Dihydroartemisinin (DHA) possesses anti-inflammatory and antioxidant properties.
Purpose Of The Study
- To evaluate DHA's therapeutic effects on acetic acid-induced UC in rats.
- To investigate DHA's impact on anti-inflammatory and necroptotic pathways (NFκB/TNF-α/RIPK1).
Main Methods
- Acetic acid-induced colitis model in rats.
- Assessment of histological, biochemical, and molecular markers.
- DHA administered via intraperitoneal injection.
Main Results
- DHA reduced UC severity, inflammation, and oxidative stress markers (MDA, TNF-α, IL-6).
- DHA increased antioxidant (GSH) and anti-inflammatory (IL-10) markers.
- DHA downregulated key proteins in apoptotic and necroptotic pathways (TNF-α, RIPK1, caspase 3).
Conclusions
- DHA exhibits protective effects against UC by mitigating oxidative stress and inflammation.
- DHA influences apoptotic and necroptotic pathways, suggesting a novel therapeutic mechanism.
- DHA represents a promising therapeutic candidate for managing ulcerative colitis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
